Literature DB >> 2080236

Cytochemical markers and DNA content of neuroendocrine cells in carcinoma of the prostate gland during tumour progression.

S Falkmer1, U Askensten, L Grimelius, P A Abrahamsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2080236

Source DB:  PubMed          Journal:  Acta Histochem Suppl        ISSN： 0567-7556


× No keyword cloud information.
  4 in total

1.  Sortilin regulates progranulin action in castration-resistant prostate cancer cells.

Authors:  Ryuta Tanimoto; Alaide Morcavallo; Mario Terracciano; Shi-Qiong Xu; Manuela Stefanello; Simone Buraschi; Kuojung G Lu; Demetrius H Bagley; Leonard G Gomella; Katia Scotlandi; Antonino Belfiore; Renato V Iozzo; Andrea Morrione
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

2.  Prostate cancer and neuroendocrine differentiation.

Authors:  M O Tan; U Karaoğlan; B Celik; O Ataoğlu; H Biri; I Bozkirli
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

3.  Neuroendocrine differentiation does not have independent prognostic value in conservatively treated prostate cancer.

Authors:  S S Jeetle; G Fisher; Z H Yang; E Stankiewicz; H Møller; C S Cooper; J Cuzick; D M Berney
Journal:  Virchows Arch       Date:  2012-07-06       Impact factor: 4.064

4.  Imaging Neurotensin Receptor in Prostate Cancer With 64Cu-Labeled Neurotensin Analogs.

Authors:  Huaifu Deng; Hui Wang; He Zhang; Mengzhe Wang; Ben Giglio; Xiaofen Ma; Guihua Jiang; Hong Yuan; Zhanhong Wu; Zibo Li
Journal:  Mol Imaging       Date:  2017 Jan-Dec       Impact factor: 4.488
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.